Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC15A1 | P46059 | 1/20 | 0.45 |
| ▸ | CTSL | P07711 | 6/20 | 0.45 |
| ▸ | CTSB | P07858 | 6/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.44 |
| ▸ | CPA1 | P15085 | 3/20 | 0.43 |
| ▸ | CTSK | P43235 | 2/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15445430 | 0.84 | SLC15A1 (0.49) | SLC15A1ALDH1A1MAPK1L3MBTL1CPA1 | |
| SCHEMBL10013280 | 0.82 | ALDH1A1 (0.50) | SLC15A1CTSLCTSBALDH1A1MAPK1 | |
| SCHEMBL16726827 | 0.82 | ALDH1A1 (0.50) | SLC15A1CTSLCTSBALDH1A1MAPK1 | |
| SCHEMBL18199537 | 0.81 | SLC15A1 (0.52) | SLC15A1CTSLCTSBALDH1A1MAPK1 | |
| SCHEMBL13915926 | 0.80 | SLC15A1 (0.48) | SLC15A1CTSLCTSBALDH1A1MAPK1 | |
| Hydrochloric Acid SCHEMBL29110345 | 0.80 | SLC15A1 (0.51) | SLC15A1CTSLCTSBALDH1A1MAPK1 | |
| Hydrochloric Acid SCHEMBL1044439 | 0.80 | SLC15A1 (0.51) | SLC15A1CTSLCTSBALDH1A1MAPK1 | |
| SCHEMBL16729374 | 0.79 | SLC15A1 (0.47) | SLC15A1CTSLCTSBALDH1A1MAPK1 | |
| SCHEMBL15437884 | 0.78 | ALDH1A1 (0.45) | SLC15A1ALDH1A1MAPK1L3MBTL1CPA1 | |
| SCHEMBL1410099 | 0.78 | CPA1 (0.45) | ALDH1A1CPA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120220799-A1 | NOVEL PROCESS | GENERICS [UK] LIMITED (GB) | 2012-08-30 | — | — | US | disclosed |
| US-20120220799-A1 | NOVEL PROCESS | GENERICS [UK] LIMITED (GB) | 2012-08-30 | — | — | US | disclosed |
| US-20110144383-A1 | PROCESS FOR PREPARING (S)-3-(AMINOMETHYL)-5-METHYLHEXANOIC ACID | MATRIX LABORATORIES LIMITED (IN) | 2011-06-16 | — | — | US | disclosed |
| US-20090286880-A1 | NOVEL PROCESS | GENERICS [UK] LIMITED (GB) | 2009-11-19 | — | — | US | disclosed |
| US-20090286880-A1 | NOVEL PROCESS | GENERICS [UK] LIMITED (GB) | 2009-11-19 | — | — | US | disclosed |
| WO-2009125427-A2 | PROCESS FOR PREPARING (S)-3-(AMINOMETHYL)-5-METHYLHEXANOIC ACID | MATRIX LABORATORIES LIMITED (IN) | 2009-10-15 | — | — | WO | disclosed |
| EP-2054375-A2 | PROCESS OF PREPARING A GAMMA-AMINO ACID | Merck Generics (UK) Limited (GB) | 2009-05-06 | — | — | EP | disclosed |
| WO-2008007145-A2 | PROCESS OF PREPARING A GAMMA-AMINO ACID | GENERICS [UK] LIMITED (GB) | 2008-01-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120220799-A1 | NOVEL PROCESS | GABRB2, GABRB1, GABRE | SLC15A1 3406/4885CTSL 2767/4885CTSB 2981/4885 |
| US-20110144383-A1 | PROCESS FOR PREPARING (S)-3-(AMINOMETHYL)-5-METHYLHEXANOIC ACID | ALKBH5, ALOX5, METTL3 | SLC15A1 4364/4885CTSL 2800/4885CTSB 4002/4885 |
| US-20090286880-A1 | NOVEL PROCESS | GABRB2, GABRB1, GABRE | SLC15A1 3406/4885CTSL 2767/4885CTSB 2981/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.